AR and prostate carcinoma: In our previous study, a lipid-shell nanobubble carrying androgen receptor double-stranded RNA (AR dsRNA) was constructed for androgen-independent prostate cancer, and was confirmed to accumulate in prostate cancer lesions and release AR dsRNA under ultrasound irradiation, thereby inhibiting the growth of prostate cancer.